Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis

Journal of Leukocyte Biology

Volumn 95, Issue 4, 2014, Pages 667-676

  Mizoguchi, Yoko ^a   Tsumura, Miyuki ^a   Okada, Satoshi ^a,b   Hirata, Osamu ^a   Minegishi, Shizuko ^c   Imai, Kohsuke ^d   Hyakuna, Nobuyuki ^e   Muramatsu, Hideki ^f   Kojima, Seiji ^f   Ozaki, Yusuke ^g   Imai, Takehide ^g   Takeda, Sachiyo ^g   Okazaki, Tetsuya ^g   Ito, Tsuyoshi ^h   Yasunaga, Shinich'iro ⁱ   Takihara, Yoshihiro ⁱ   Bryant, Vanessa L ^b   Kong, Xiao Fei ^b   Cypowyj, Sophie ^b   Boisson Dupuis, Stéphanie ^b,j   Puel, Anne ^j   Casanova, Jean Laurent ^b,j   Morio, Tomohiro ^d   Kobayashi, Masao ^a   more..

^a HIROSHIMA UNIVERSITY   (Japan)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

ⁱ HIROSHIMA UNIVERSITY   (Japan)

^j IMAGINE INSTITUTE   (France)

more..

Author keywords

CMCD; GOF; pSTAT1; STAT1

Indexed keywords

GAMMA INTERFERON; STAT1 PROTEIN; STAUROSPORINE;

ADULT; ALLELE; ARTICLE; BRONCHIECTASIS; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONCURRENT INFECTION; FEMALE; FLOW CYTOMETRY; GAIN OF FUNCTION MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOBLOTTING; JAPAN; MALE; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; PRIORITY JOURNAL; SYMPTOM; TRANSIENT EXPRESSION; VIRUS INFECTION;

CMCD; GOF; PSTAT1; STAT1;

ALLELES; ANTIGENS, CD14; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; DNA; FLOW CYTOMETRY; HUMANS; MUTATION; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR;

EID: 84899791876     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0513250     Document Type: Article

References (44)

1. Kirkpatrick, C. H. (2001) Chronic mucocutaneous candidiasis. Pediatr. Infect. Dis. J. 20, 197-206.
2. Lilic, D. (2002) New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr. Opin. Infect. Dis. 15, 143-147.
3. Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., Metin, A., Karasuyama, H. (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448, 1058-1062.
4. Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., et al. (2007) STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357, 1608-1619.
5. De Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A., Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Jannière, L., Rose, Y., de Suremain, M., et al. (2010) Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89, 381-402.
6. Puel, A., Picard, C., Cypowyj, S., Lilic, D., Abel, L., Casanova, J. L. (2010) Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr. Opin. Immunol. 22, 467-474.
7. Minegishi, Y., Saito, M., Nagasawa, M., Takada, H., Hara, T., Tsuchiya, S., Agematsu, K., Yamada, M., Kawamura, N., Ariga, T., Tsuge, I., Karasuyama, H. (2009) Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J. Exp. Med. 206, 1291-1301.
8. De Beaucoudrey, L., Puel, A., Filipe-Santos, O., Cobat, A., Ghandil, P., Chrabieh, M., Feinberg, J., von Bernuth, H., Samarina, A., Janniere, L., et al. (2008) Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205, 1543-1550.
9. Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., Davis, J., Hsu, A., Asher, A. I., O'Shea, J., Holland, S. M., Paul, W. E., Douek, D. C. (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773-776.
10. Ma, C. S., Chew, G. Y., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., Cook, M. C. (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205, 1551-1557.
11. Kisand, K., Boe Wolff, A. S., Podkrajsek, K. T., Tserel, L., Link, M., Kisand, K. V., Ersvaer, E., Perheentupa, J., Erichsen, M. M., Bratanic, N., et al. (2010) Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207, 299-308.
12. Puel, A., Doffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A., Ouachee-Chardin, M., Toulon, A., Bustamante, J., et al. (2010) Autoantibodies against IL-17A, IL-17F, and. IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207, 291-297.
13. Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65-68.
14. Cypowyj, S., Picard, C., Marodi, L., Casanova, J. L., Puel, A. (2012) Immunity to infection in IL-17-deficient mice and humans. Eur. J. Immunol. 42, 2246-2254.
15. Marodi, L., Cypowyj, S., Toth, B., Chernyshova, L., Puel, A., Casanova, J. L. (2012) Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J. Allergy Clin. Immunol. 130, 1019-1027.
16. Puel, A., Cypowyj, S., Marodi, L., Abel, L., Picard, C., Casanova, J. L. (2012) Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr. Opin. Allergy Clin. Immunol. 12, 616-622.
17. Alcais, A., Quintana-Murci, L., Thaler, D. S., Schurr, E., Abel, L., Casanova, J. L. (2010) Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann. N. Y. Acad. Sci. 1214, 18-33.
18. Liu, L., Okada, S., Kong, X. F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., et al. (2011) Gainof-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635-1648.
19. Van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A. J., Smits-van der Graaf, C. A., Kullberg, B. J., van der Meer, J. W., Lilic, D., Veltman, J. A., Netea, M. G. (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54-61.
20. Takezaki, S., Yamada, M., Kato, M., Park, M. J., Maruyama, K., Yamazaki, Y., Chida, N., Ohara, O., Kobayashi, I., Ariga, T. (2012) Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J. Immunol. 189, 1521-1526.
21. Smeekens, S. P., Plantinga, T. S., van de Veerdonk, F. L., Heinhuis, B., Hoischen, A., Joosten, L. A., Arkwright, P. D., Gennery, A., Kullberg, B. J., Veltman, J. A., Lilic, D., van der Meer, J. W., Netea, M. G. (2011) STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS One 6, e29248.
22. Chapgier, A., Boisson-Dupuis, S., Jouanguy, E., Vogt, G., Feinberg, J., Prochnicka-Chalufour, A., Casrouge, A., Yang, K., Soudais, C., Fieschi, C., et al. (2006) Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet. 2, e131.
23. Kong, X. F., Ciancanelli, M., Al-Hajjar, S., Alsina, L., Zumwalt, T., Bustamante, J., Feinberg, J., Audry, M., Prando, C., Bryant, V., et al. (2010) A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Blood 116, 5895-5906.
24. Tsumura, M., Okada, S., Sakai, H., Yasunaga, S., Ohtsubo, M., Murata, T., Obata, H., Yasumi, T., Kong, X. F., Abhyankar, A., et al. (2012) Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease. Hum. Mutat. 33, 1377-1387.
25. Uzel, G., Sampaio, E. P., Lawrence, M. G., Hsu, A. P., Hackett, M., Dorsey, M. J., Noel, R. J., Verbsky, J. W., Freeman, A. F., Janssen, E., et al. (2013) Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-Xlinked-like syndrome. J. Allergy Clin. Immunol. 131, 1611-1623.
26. Romberg, N., Morbach, H., Lawrence, M. G., Kim, S., Kang, I., Holland, S. M., Milner, J. D., Meffre, E. (2013) Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J. Allergy Clin. Immunol. 131, 1691-1693.
27. Bernabei, P., Coccia, E. M., Rigamonti, L., Bosticardo, M., Forni, G., Pestka, S., Krause, C. D., Battistini, A., Novelli, F. (2001) Interferon-γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J. Leukoc. Biol. 70, 950-960.
28. Bach, E. A., Aguet, M., Schreiber, R. D. (1997) The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563-591.
29. Van Boxel-Dezaire, A. H., Stark, G. R. (2007) Cell type-specific signaling in response to interferon-γ. Curr. Top. Microbiol. Immunol. 316, 119-154.
30. Kong, X. F., Vogt, G., Itan, Y., Macura-Biegun, A., Szaflarska, A., Kowalczyk, D., Chapgier, A., Abhyankar, A., Furthner, D., Khayat, C. D., et al. (2013) Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum. Mol. Genet. 22, 769-781.
31. Fleisher, T. A., Dorman, S. E., Anderson, J. A., Vail, M., Brown, M. R., Holland, S. M. (1999) Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin. Immunol. 90, 425-430.
32. Chapgier, A., Kong, X. F., Boisson-Dupuis, S., Jouanguy, E., Averbuch, D., Feinberg, J., Zhang, S. Y., Bustamante, J., Vogt, G., Lejeune, J., Mayola, E., de Beaucoudrey, L., Abel, L., Engelhard, D., Casanova, J. L. (2009) A partial form of recessive STAT1 deficiency in humans. J. Clin. Invest. 119, 1502-1514.
33. Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P., et al. (2012) Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science 337, 1684-1688.
34. Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S., Harris, J., Holland, S. M., Schreiber, R. D., Casanova, J. L. (2001) Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293, 300-303.
35. Hori, T., Ohnishi, H., Teramoto, T., Tsubouchi, K., Naiki, T., Hirose, Y., Ohara, O., Seishima, M., Kaneko, H., Fukao, T., Kondo, N. (2012) Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism. J. Clin. Immunol. 32, 1213-1220.
36. Toth, B., Mehes, L., Tasko, S., Szalai, Z., Tulassay, Z., Cypowyj, S., Casanova, J. L., Puel, A., Marodi, L. (2012) Herpes in STAT1 deficiency. Lancet 379, 2500.
37. Ten Hoeve, J., de Jesus Ibarra-Sanchez, M., Fu, Y., Zhu, W., Tremblay, M., David, M., Shuai, K. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22, 5662-5668.
38. Chen, G. H., McDonald, R. A., Wells, J. C., Huffnagle, G. B., Lukacs, N. W., Toews, G. B. (2005) The γ interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun. 73, 1788-1796.
39. Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L. G., Wood, R., Harrison, T. S. (2012) Adjunctive interferon-γ immunotherapy for the treatment of HIVassociated cryptococcal meningitis: a randomized controlled trial. AIDS 26, 1105-1113.
40. Wang, X., Lin, Z., Gao, L., Wang, A., Wan, Z., Chen, W., Yang, Y., Li, R. (2013) Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis. J. Allergy Clin. Immunol. 131, 1242-1243.
41. Sampaio, E. P., Hsu, A. P., Pechacek, J., Bax, H. I., Dias, D. L., Paulson, M. L., Chandrasekaran, P., Rosen, L. B., Carvalho, D. S., Ding, L., et al. (2013) Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J. Allergy Clin. Immunol. 131, 1624-1634.
42. Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., Al Ghonaium, A., Tufenkeji, H., Frayha, H., Al-Gazlan, S., Al-Rayes, H., Schreiber, R. D., Gresser, I., Casanova, J. L. (2003) Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388-391.
43. Chapgier, A., Wynn, R. F., Jouanguy, E., Filipe-Santos, O., Zhang, S., Feinberg, J., Hawkins, K., Casanova, J. L., Arkwright, P. D. (2006) Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J. Immunol. 176, 5078-5083.
44. Boisson-Dupuis, S., Kong, X. F., Okada, S., Cypowyj, S., Puel, A., Abel, L., Casanova, J. L. (2012) Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24, 364-378.